The biologic DMARDs rituximab and abatacept were associated with an increased risk for incident cancers in patients with RA ...

The anti-inflammatory baricitinib is normally used to treat rheumatoid arthritis. Trials suggest it can cut death risk by about a fifth in patients needing hospital care for severe Covid.

researchers applied machine learning algorithms to a biomedical knowledge graph to uncover the potential of baricitinib. This ...